Pharmacoeconomic evaluation of COPD: Stratification of outcomes and costs according to initial drug therapy

Daniel E. Hilleman; E. C. Wadibia; B. Shinn

Back

Pharmacoeconomic evaluation of COPD: Stratification of outcomes and costs according to initial drug therapy

Journal article

Peer reviewed

Pharmacoeconomic evaluation of COPD: Stratification of outcomes and costs according to initial drug therapy

Daniel E. Hilleman, E. C. Wadibia and B. Shinn

Chest, Vol.110(4 SUPPL.), p.36S

110

10/01/1996

Abstract

Pulmonary and Respiratory Medicine

Critical Care and Intensive Care Medicine

Cardiology and Cardiovascular Medicine

Introduction: The outcomes and treatment costs of a cohort of 355 patients (pts) with COPD were evaluated. Methods: Pts with moderate to severe (predicted FEV,

Metrics

5 Record Views

Details

Title: Pharmacoeconomic evaluation of COPD
Creators: Daniel E. Hilleman (Author) - Department of Pharmacy Practice
E. C. Wadibia (Author) - Creighton University
B. Shinn (Author) - Creighton University
Publication Details: Chest, Vol.110(4 SUPPL.), p.36S
Series: 110
Identifiers: 991005930529602656
Academic Unit: Pharmacy Practice
Language: English
Resource Type: Journal article

Pharmacoeconomic evaluation of COPD: Stratification of outcomes and costs according to initial drug therapy

Abstract

Related links

Metrics

Details